nodes	percent_of_prediction	percent_of_DWPC	metapath
Histamine Phosphate—CYP3A4—bone cancer	0.733	1	CbGaD
Histamine Phosphate—SLC22A2—Cisplatin—bone cancer	0.0578	0.645	CbGbCtD
Histamine Phosphate—CYP2C9—Cisplatin—bone cancer	0.0158	0.177	CbGbCtD
Histamine Phosphate—CYP2D6—Doxorubicin—bone cancer	0.00971	0.108	CbGbCtD
Histamine Phosphate—CYP3A4—Doxorubicin—bone cancer	0.00618	0.069	CbGbCtD
Histamine Phosphate—Risedronate—PTGS2—bone cancer	0.00326	1	CrCbGaD
Histamine Phosphate—HNMT—Metapathway biotransformation—CYP4V2—bone cancer	0.00203	0.131	CbGpPWpGaD
Histamine Phosphate—Anorexia—Cisplatin—bone cancer	0.000503	0.00317	CcSEcCtD
Histamine Phosphate—Hypotension—Cisplatin—bone cancer	0.000493	0.00311	CcSEcCtD
Histamine Phosphate—Abdominal discomfort—Methotrexate—bone cancer	0.000489	0.00308	CcSEcCtD
Histamine Phosphate—Gastritis—Epirubicin—bone cancer	0.000488	0.00307	CcSEcCtD
Histamine Phosphate—Muscular weakness—Epirubicin—bone cancer	0.000487	0.00306	CcSEcCtD
Histamine Phosphate—Cardiac arrest—Doxorubicin—bone cancer	0.000485	0.00306	CcSEcCtD
Histamine Phosphate—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000481	0.00303	CcSEcCtD
Histamine Phosphate—Abdominal distension—Epirubicin—bone cancer	0.00048	0.00302	CcSEcCtD
Histamine Phosphate—Blood creatinine increased—Doxorubicin—bone cancer	0.000478	0.00301	CcSEcCtD
Histamine Phosphate—Dysphagia—Epirubicin—bone cancer	0.000477	0.003	CcSEcCtD
Histamine Phosphate—Asthma—Epirubicin—bone cancer	0.000477	0.003	CcSEcCtD
Histamine Phosphate—Neutropenia—Methotrexate—bone cancer	0.000477	0.003	CcSEcCtD
Histamine Phosphate—Dehydration—Doxorubicin—bone cancer	0.000475	0.00299	CcSEcCtD
Histamine Phosphate—Paraesthesia—Cisplatin—bone cancer	0.000474	0.00299	CcSEcCtD
Histamine Phosphate—Upper respiratory tract infection—Methotrexate—bone cancer	0.000474	0.00298	CcSEcCtD
Histamine Phosphate—Eosinophilia—Epirubicin—bone cancer	0.000472	0.00297	CcSEcCtD
Histamine Phosphate—Dyspnoea—Cisplatin—bone cancer	0.000471	0.00296	CcSEcCtD
Histamine Phosphate—Dry skin—Doxorubicin—bone cancer	0.000468	0.00295	CcSEcCtD
Histamine Phosphate—Abdominal pain upper—Doxorubicin—bone cancer	0.000466	0.00294	CcSEcCtD
Histamine Phosphate—Decreased appetite—Cisplatin—bone cancer	0.000459	0.00289	CcSEcCtD
Histamine Phosphate—Pneumonia—Methotrexate—bone cancer	0.000457	0.00288	CcSEcCtD
Histamine Phosphate—Gastrointestinal disorder—Cisplatin—bone cancer	0.000456	0.00287	CcSEcCtD
Histamine Phosphate—Infestation—Methotrexate—bone cancer	0.000454	0.00286	CcSEcCtD
Histamine Phosphate—Infestation NOS—Methotrexate—bone cancer	0.000454	0.00286	CcSEcCtD
Histamine Phosphate—Gastritis—Doxorubicin—bone cancer	0.000452	0.00284	CcSEcCtD
Histamine Phosphate—Pain—Cisplatin—bone cancer	0.000452	0.00284	CcSEcCtD
Histamine Phosphate—Muscular weakness—Doxorubicin—bone cancer	0.00045	0.00284	CcSEcCtD
Histamine Phosphate—Renal failure—Methotrexate—bone cancer	0.000447	0.00281	CcSEcCtD
Histamine Phosphate—Neutropenia—Epirubicin—bone cancer	0.000446	0.00281	CcSEcCtD
Histamine Phosphate—Abdominal distension—Doxorubicin—bone cancer	0.000444	0.0028	CcSEcCtD
Histamine Phosphate—Upper respiratory tract infection—Epirubicin—bone cancer	0.000443	0.00279	CcSEcCtD
Histamine Phosphate—Stomatitis—Methotrexate—bone cancer	0.000443	0.00279	CcSEcCtD
Histamine Phosphate—Asthma—Doxorubicin—bone cancer	0.000441	0.00278	CcSEcCtD
Histamine Phosphate—Dysphagia—Doxorubicin—bone cancer	0.000441	0.00278	CcSEcCtD
Histamine Phosphate—Eosinophilia—Doxorubicin—bone cancer	0.000437	0.00275	CcSEcCtD
Histamine Phosphate—Feeling abnormal—Cisplatin—bone cancer	0.000435	0.00274	CcSEcCtD
Histamine Phosphate—Weight increased—Epirubicin—bone cancer	0.000434	0.00273	CcSEcCtD
Histamine Phosphate—Weight decreased—Epirubicin—bone cancer	0.000431	0.00272	CcSEcCtD
Histamine Phosphate—Pneumonia—Epirubicin—bone cancer	0.000428	0.00269	CcSEcCtD
Histamine Phosphate—Infestation NOS—Epirubicin—bone cancer	0.000425	0.00268	CcSEcCtD
Histamine Phosphate—Infestation—Epirubicin—bone cancer	0.000425	0.00268	CcSEcCtD
Histamine Phosphate—HRH4—GPCRs, Other—GRM1—bone cancer	0.000424	0.0273	CbGpPWpGaD
Histamine Phosphate—Renal failure—Epirubicin—bone cancer	0.000418	0.00263	CcSEcCtD
Histamine Phosphate—Body temperature increased—Cisplatin—bone cancer	0.000417	0.00263	CcSEcCtD
Histamine Phosphate—Stomatitis—Epirubicin—bone cancer	0.000414	0.00261	CcSEcCtD
Histamine Phosphate—Neutropenia—Doxorubicin—bone cancer	0.000413	0.0026	CcSEcCtD
Histamine Phosphate—Upper respiratory tract infection—Doxorubicin—bone cancer	0.00041	0.00258	CcSEcCtD
Histamine Phosphate—HNMT—Metapathway biotransformation—CYP3A4—bone cancer	0.000402	0.0258	CbGpPWpGaD
Histamine Phosphate—Weight increased—Doxorubicin—bone cancer	0.000402	0.00253	CcSEcCtD
Histamine Phosphate—Weight decreased—Doxorubicin—bone cancer	0.000399	0.00251	CcSEcCtD
Histamine Phosphate—Pneumonia—Doxorubicin—bone cancer	0.000396	0.00249	CcSEcCtD
Histamine Phosphate—Infestation NOS—Doxorubicin—bone cancer	0.000393	0.00248	CcSEcCtD
Histamine Phosphate—Infestation—Doxorubicin—bone cancer	0.000393	0.00248	CcSEcCtD
Histamine Phosphate—CYP2D6—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.000391	0.0251	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000389	0.025	CbGpPWpGaD
Histamine Phosphate—Hypersensitivity—Cisplatin—bone cancer	0.000389	0.00245	CcSEcCtD
Histamine Phosphate—Renal failure—Doxorubicin—bone cancer	0.000387	0.00244	CcSEcCtD
Histamine Phosphate—CYP2C9—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000386	0.0248	CbGpPWpGaD
Histamine Phosphate—Stomatitis—Doxorubicin—bone cancer	0.000384	0.00241	CcSEcCtD
Histamine Phosphate—Hypoaesthesia—Epirubicin—bone cancer	0.00038	0.00239	CcSEcCtD
Histamine Phosphate—Asthenia—Cisplatin—bone cancer	0.000379	0.00239	CcSEcCtD
Histamine Phosphate—Cardiac disorder—Methotrexate—bone cancer	0.000379	0.00238	CcSEcCtD
Histamine Phosphate—Oedema peripheral—Epirubicin—bone cancer	0.000376	0.00237	CcSEcCtD
Histamine Phosphate—Connective tissue disorder—Epirubicin—bone cancer	0.000375	0.00236	CcSEcCtD
Histamine Phosphate—Angiopathy—Methotrexate—bone cancer	0.00037	0.00233	CcSEcCtD
Histamine Phosphate—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.000369	0.0237	CbGpPWpGaD
Histamine Phosphate—Mediastinal disorder—Methotrexate—bone cancer	0.000368	0.00231	CcSEcCtD
Histamine Phosphate—Chills—Methotrexate—bone cancer	0.000366	0.0023	CcSEcCtD
Histamine Phosphate—Diarrhoea—Cisplatin—bone cancer	0.000361	0.00228	CcSEcCtD
Histamine Phosphate—Mental disorder—Methotrexate—bone cancer	0.000357	0.00225	CcSEcCtD
Histamine Phosphate—Malnutrition—Methotrexate—bone cancer	0.000355	0.00224	CcSEcCtD
Histamine Phosphate—Erythema—Methotrexate—bone cancer	0.000355	0.00224	CcSEcCtD
Histamine Phosphate—Cardiac disorder—Epirubicin—bone cancer	0.000354	0.00223	CcSEcCtD
Histamine Phosphate—Flushing—Epirubicin—bone cancer	0.000354	0.00223	CcSEcCtD
Histamine Phosphate—Hypoaesthesia—Doxorubicin—bone cancer	0.000351	0.00221	CcSEcCtD
Histamine Phosphate—Oedema peripheral—Doxorubicin—bone cancer	0.000348	0.00219	CcSEcCtD
Histamine Phosphate—Dysgeusia—Methotrexate—bone cancer	0.000348	0.00219	CcSEcCtD
Histamine Phosphate—Connective tissue disorder—Doxorubicin—bone cancer	0.000347	0.00219	CcSEcCtD
Histamine Phosphate—Angiopathy—Epirubicin—bone cancer	0.000346	0.00218	CcSEcCtD
Histamine Phosphate—Mediastinal disorder—Epirubicin—bone cancer	0.000344	0.00217	CcSEcCtD
Histamine Phosphate—HNMT—Metapathway biotransformation—GSTP1—bone cancer	0.000344	0.0221	CbGpPWpGaD
Histamine Phosphate—Back pain—Methotrexate—bone cancer	0.000343	0.00216	CcSEcCtD
Histamine Phosphate—Chills—Epirubicin—bone cancer	0.000343	0.00216	CcSEcCtD
Histamine Phosphate—Arrhythmia—Epirubicin—bone cancer	0.000341	0.00215	CcSEcCtD
Histamine Phosphate—Vomiting—Cisplatin—bone cancer	0.000336	0.00211	CcSEcCtD
Histamine Phosphate—Mental disorder—Epirubicin—bone cancer	0.000334	0.00211	CcSEcCtD
Histamine Phosphate—Rash—Cisplatin—bone cancer	0.000333	0.0021	CcSEcCtD
Histamine Phosphate—Dermatitis—Cisplatin—bone cancer	0.000333	0.00209	CcSEcCtD
Histamine Phosphate—Malnutrition—Epirubicin—bone cancer	0.000332	0.00209	CcSEcCtD
Histamine Phosphate—Erythema—Epirubicin—bone cancer	0.000332	0.00209	CcSEcCtD
Histamine Phosphate—Ill-defined disorder—Methotrexate—bone cancer	0.000329	0.00207	CcSEcCtD
Histamine Phosphate—Anaemia—Methotrexate—bone cancer	0.000328	0.00207	CcSEcCtD
Histamine Phosphate—Cardiac disorder—Doxorubicin—bone cancer	0.000328	0.00206	CcSEcCtD
Histamine Phosphate—Flushing—Doxorubicin—bone cancer	0.000328	0.00206	CcSEcCtD
Histamine Phosphate—Flatulence—Epirubicin—bone cancer	0.000327	0.00206	CcSEcCtD
Histamine Phosphate—Dysgeusia—Epirubicin—bone cancer	0.000325	0.00205	CcSEcCtD
Histamine Phosphate—Back pain—Epirubicin—bone cancer	0.000321	0.00202	CcSEcCtD
Histamine Phosphate—Angiopathy—Doxorubicin—bone cancer	0.00032	0.00202	CcSEcCtD
Histamine Phosphate—Malaise—Methotrexate—bone cancer	0.00032	0.00202	CcSEcCtD
Histamine Phosphate—Muscle spasms—Epirubicin—bone cancer	0.000319	0.00201	CcSEcCtD
Histamine Phosphate—Vertigo—Methotrexate—bone cancer	0.000319	0.00201	CcSEcCtD
Histamine Phosphate—Mediastinal disorder—Doxorubicin—bone cancer	0.000318	0.002	CcSEcCtD
Histamine Phosphate—Leukopenia—Methotrexate—bone cancer	0.000318	0.002	CcSEcCtD
Histamine Phosphate—Chills—Doxorubicin—bone cancer	0.000317	0.002	CcSEcCtD
Histamine Phosphate—Arrhythmia—Doxorubicin—bone cancer	0.000316	0.00199	CcSEcCtD
Histamine Phosphate—Nausea—Cisplatin—bone cancer	0.000314	0.00198	CcSEcCtD
Histamine Phosphate—Cough—Methotrexate—bone cancer	0.00031	0.00195	CcSEcCtD
Histamine Phosphate—Mental disorder—Doxorubicin—bone cancer	0.000309	0.00195	CcSEcCtD
Histamine Phosphate—Ill-defined disorder—Epirubicin—bone cancer	0.000308	0.00194	CcSEcCtD
Histamine Phosphate—Convulsion—Methotrexate—bone cancer	0.000308	0.00194	CcSEcCtD
Histamine Phosphate—Erythema—Doxorubicin—bone cancer	0.000307	0.00194	CcSEcCtD
Histamine Phosphate—Malnutrition—Doxorubicin—bone cancer	0.000307	0.00194	CcSEcCtD
Histamine Phosphate—Anaemia—Epirubicin—bone cancer	0.000307	0.00193	CcSEcCtD
Histamine Phosphate—Flatulence—Doxorubicin—bone cancer	0.000303	0.00191	CcSEcCtD
Histamine Phosphate—Chest pain—Methotrexate—bone cancer	0.000302	0.0019	CcSEcCtD
Histamine Phosphate—Myalgia—Methotrexate—bone cancer	0.000302	0.0019	CcSEcCtD
Histamine Phosphate—Arthralgia—Methotrexate—bone cancer	0.000302	0.0019	CcSEcCtD
Histamine Phosphate—Dysgeusia—Doxorubicin—bone cancer	0.000301	0.0019	CcSEcCtD
Histamine Phosphate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.0003	0.00189	CcSEcCtD
Histamine Phosphate—Malaise—Epirubicin—bone cancer	0.0003	0.00189	CcSEcCtD
Histamine Phosphate—HRH4—GPCRs, Other—SMO—bone cancer	0.000299	0.0192	CbGpPWpGaD
Histamine Phosphate—Discomfort—Methotrexate—bone cancer	0.000299	0.00188	CcSEcCtD
Histamine Phosphate—Vertigo—Epirubicin—bone cancer	0.000299	0.00188	CcSEcCtD
Histamine Phosphate—Leukopenia—Epirubicin—bone cancer	0.000297	0.00187	CcSEcCtD
Histamine Phosphate—Back pain—Doxorubicin—bone cancer	0.000297	0.00187	CcSEcCtD
Histamine Phosphate—Muscle spasms—Doxorubicin—bone cancer	0.000296	0.00186	CcSEcCtD
Histamine Phosphate—Palpitations—Epirubicin—bone cancer	0.000294	0.00185	CcSEcCtD
Histamine Phosphate—Confusional state—Methotrexate—bone cancer	0.000292	0.00184	CcSEcCtD
Histamine Phosphate—Cough—Epirubicin—bone cancer	0.00029	0.00183	CcSEcCtD
Histamine Phosphate—Anaphylactic shock—Methotrexate—bone cancer	0.00029	0.00182	CcSEcCtD
Histamine Phosphate—Convulsion—Epirubicin—bone cancer	0.000288	0.00181	CcSEcCtD
Histamine Phosphate—Infection—Methotrexate—bone cancer	0.000288	0.00181	CcSEcCtD
Histamine Phosphate—Hypertension—Epirubicin—bone cancer	0.000287	0.00181	CcSEcCtD
Histamine Phosphate—Ill-defined disorder—Doxorubicin—bone cancer	0.000285	0.0018	CcSEcCtD
Histamine Phosphate—Nervous system disorder—Methotrexate—bone cancer	0.000284	0.00179	CcSEcCtD
Histamine Phosphate—Anaemia—Doxorubicin—bone cancer	0.000284	0.00179	CcSEcCtD
Histamine Phosphate—Thrombocytopenia—Methotrexate—bone cancer	0.000284	0.00179	CcSEcCtD
Histamine Phosphate—Myalgia—Epirubicin—bone cancer	0.000283	0.00178	CcSEcCtD
Histamine Phosphate—Chest pain—Epirubicin—bone cancer	0.000283	0.00178	CcSEcCtD
Histamine Phosphate—Arthralgia—Epirubicin—bone cancer	0.000283	0.00178	CcSEcCtD
Histamine Phosphate—Anxiety—Epirubicin—bone cancer	0.000282	0.00178	CcSEcCtD
Histamine Phosphate—Skin disorder—Methotrexate—bone cancer	0.000281	0.00177	CcSEcCtD
Histamine Phosphate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000281	0.00177	CcSEcCtD
Histamine Phosphate—Hyperhidrosis—Methotrexate—bone cancer	0.00028	0.00176	CcSEcCtD
Histamine Phosphate—Discomfort—Epirubicin—bone cancer	0.00028	0.00176	CcSEcCtD
Histamine Phosphate—Malaise—Doxorubicin—bone cancer	0.000277	0.00175	CcSEcCtD
Histamine Phosphate—Dry mouth—Epirubicin—bone cancer	0.000277	0.00174	CcSEcCtD
Histamine Phosphate—Vertigo—Doxorubicin—bone cancer	0.000276	0.00174	CcSEcCtD
Histamine Phosphate—Anorexia—Methotrexate—bone cancer	0.000276	0.00174	CcSEcCtD
Histamine Phosphate—Leukopenia—Doxorubicin—bone cancer	0.000275	0.00173	CcSEcCtD
Histamine Phosphate—Confusional state—Epirubicin—bone cancer	0.000273	0.00172	CcSEcCtD
Histamine Phosphate—Palpitations—Doxorubicin—bone cancer	0.000272	0.00171	CcSEcCtD
Histamine Phosphate—Anaphylactic shock—Epirubicin—bone cancer	0.000271	0.00171	CcSEcCtD
Histamine Phosphate—Hypotension—Methotrexate—bone cancer	0.000271	0.0017	CcSEcCtD
Histamine Phosphate—Infection—Epirubicin—bone cancer	0.000269	0.0017	CcSEcCtD
Histamine Phosphate—Cough—Doxorubicin—bone cancer	0.000268	0.00169	CcSEcCtD
Histamine Phosphate—Shock—Epirubicin—bone cancer	0.000267	0.00168	CcSEcCtD
Histamine Phosphate—Convulsion—Doxorubicin—bone cancer	0.000266	0.00168	CcSEcCtD
Histamine Phosphate—Nervous system disorder—Epirubicin—bone cancer	0.000266	0.00167	CcSEcCtD
Histamine Phosphate—Thrombocytopenia—Epirubicin—bone cancer	0.000266	0.00167	CcSEcCtD
Histamine Phosphate—Hypertension—Doxorubicin—bone cancer	0.000265	0.00167	CcSEcCtD
Histamine Phosphate—Tachycardia—Epirubicin—bone cancer	0.000265	0.00167	CcSEcCtD
Histamine Phosphate—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000264	0.00166	CcSEcCtD
Histamine Phosphate—Skin disorder—Epirubicin—bone cancer	0.000263	0.00166	CcSEcCtD
Histamine Phosphate—HRH3—G alpha (i) signalling events—RGS1—bone cancer	0.000263	0.0169	CbGpPWpGaD
Histamine Phosphate—HRH3—G alpha (i) signalling events—GRM4—bone cancer	0.000263	0.0169	CbGpPWpGaD
Histamine Phosphate—Hyperhidrosis—Epirubicin—bone cancer	0.000262	0.00165	CcSEcCtD
Histamine Phosphate—Insomnia—Methotrexate—bone cancer	0.000262	0.00165	CcSEcCtD
Histamine Phosphate—Arthralgia—Doxorubicin—bone cancer	0.000262	0.00165	CcSEcCtD
Histamine Phosphate—Chest pain—Doxorubicin—bone cancer	0.000262	0.00165	CcSEcCtD
Histamine Phosphate—Myalgia—Doxorubicin—bone cancer	0.000262	0.00165	CcSEcCtD
Histamine Phosphate—Anxiety—Doxorubicin—bone cancer	0.000261	0.00164	CcSEcCtD
Histamine Phosphate—Paraesthesia—Methotrexate—bone cancer	0.00026	0.00164	CcSEcCtD
Histamine Phosphate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.00026	0.00164	CcSEcCtD
Histamine Phosphate—Discomfort—Doxorubicin—bone cancer	0.000259	0.00163	CcSEcCtD
Histamine Phosphate—Anorexia—Epirubicin—bone cancer	0.000259	0.00163	CcSEcCtD
Histamine Phosphate—Dyspnoea—Methotrexate—bone cancer	0.000258	0.00163	CcSEcCtD
Histamine Phosphate—Dry mouth—Doxorubicin—bone cancer	0.000256	0.00161	CcSEcCtD
Histamine Phosphate—Dyspepsia—Methotrexate—bone cancer	0.000255	0.00161	CcSEcCtD
Histamine Phosphate—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000254	0.0163	CbGpPWpGaD
Histamine Phosphate—Hypotension—Epirubicin—bone cancer	0.000253	0.0016	CcSEcCtD
Histamine Phosphate—Confusional state—Doxorubicin—bone cancer	0.000253	0.00159	CcSEcCtD
Histamine Phosphate—Decreased appetite—Methotrexate—bone cancer	0.000252	0.00159	CcSEcCtD
Histamine Phosphate—Anaphylactic shock—Doxorubicin—bone cancer	0.000251	0.00158	CcSEcCtD
Histamine Phosphate—Gastrointestinal disorder—Methotrexate—bone cancer	0.00025	0.00158	CcSEcCtD
Histamine Phosphate—Fatigue—Methotrexate—bone cancer	0.00025	0.00157	CcSEcCtD
Histamine Phosphate—Infection—Doxorubicin—bone cancer	0.000249	0.00157	CcSEcCtD
Histamine Phosphate—Pain—Methotrexate—bone cancer	0.000248	0.00156	CcSEcCtD
Histamine Phosphate—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000247	0.00156	CcSEcCtD
Histamine Phosphate—Shock—Doxorubicin—bone cancer	0.000247	0.00155	CcSEcCtD
Histamine Phosphate—Nervous system disorder—Doxorubicin—bone cancer	0.000246	0.00155	CcSEcCtD
Histamine Phosphate—Thrombocytopenia—Doxorubicin—bone cancer	0.000246	0.00155	CcSEcCtD
Histamine Phosphate—Insomnia—Epirubicin—bone cancer	0.000245	0.00154	CcSEcCtD
Histamine Phosphate—Tachycardia—Doxorubicin—bone cancer	0.000245	0.00154	CcSEcCtD
Histamine Phosphate—Skin disorder—Doxorubicin—bone cancer	0.000244	0.00153	CcSEcCtD
Histamine Phosphate—Paraesthesia—Epirubicin—bone cancer	0.000244	0.00153	CcSEcCtD
Histamine Phosphate—Hyperhidrosis—Doxorubicin—bone cancer	0.000243	0.00153	CcSEcCtD
Histamine Phosphate—Dyspnoea—Epirubicin—bone cancer	0.000242	0.00152	CcSEcCtD
Histamine Phosphate—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000239	0.0154	CbGpPWpGaD
Histamine Phosphate—Anorexia—Doxorubicin—bone cancer	0.000239	0.00151	CcSEcCtD
Histamine Phosphate—Feeling abnormal—Methotrexate—bone cancer	0.000239	0.0015	CcSEcCtD
Histamine Phosphate—Dyspepsia—Epirubicin—bone cancer	0.000239	0.0015	CcSEcCtD
Histamine Phosphate—Gastrointestinal pain—Methotrexate—bone cancer	0.000237	0.00149	CcSEcCtD
Histamine Phosphate—Decreased appetite—Epirubicin—bone cancer	0.000236	0.00148	CcSEcCtD
Histamine Phosphate—Hypotension—Doxorubicin—bone cancer	0.000234	0.00148	CcSEcCtD
Histamine Phosphate—Gastrointestinal disorder—Epirubicin—bone cancer	0.000234	0.00147	CcSEcCtD
Histamine Phosphate—Fatigue—Epirubicin—bone cancer	0.000234	0.00147	CcSEcCtD
Histamine Phosphate—Pain—Epirubicin—bone cancer	0.000232	0.00146	CcSEcCtD
Histamine Phosphate—Constipation—Epirubicin—bone cancer	0.000232	0.00146	CcSEcCtD
Histamine Phosphate—Urticaria—Methotrexate—bone cancer	0.00023	0.00145	CcSEcCtD
Histamine Phosphate—Body temperature increased—Methotrexate—bone cancer	0.000229	0.00144	CcSEcCtD
Histamine Phosphate—Abdominal pain—Methotrexate—bone cancer	0.000229	0.00144	CcSEcCtD
Histamine Phosphate—HRH4—G alpha (i) signalling events—GRM4—bone cancer	0.000229	0.0147	CbGpPWpGaD
Histamine Phosphate—HRH4—G alpha (i) signalling events—RGS1—bone cancer	0.000229	0.0147	CbGpPWpGaD
Histamine Phosphate—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000229	0.00144	CcSEcCtD
Histamine Phosphate—Insomnia—Doxorubicin—bone cancer	0.000227	0.00143	CcSEcCtD
Histamine Phosphate—Paraesthesia—Doxorubicin—bone cancer	0.000225	0.00142	CcSEcCtD
Histamine Phosphate—CYP2D6—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000224	0.0144	CbGpPWpGaD
Histamine Phosphate—Dyspnoea—Doxorubicin—bone cancer	0.000224	0.00141	CcSEcCtD
Histamine Phosphate—Feeling abnormal—Epirubicin—bone cancer	0.000223	0.00141	CcSEcCtD
Histamine Phosphate—Gastrointestinal pain—Epirubicin—bone cancer	0.000222	0.0014	CcSEcCtD
Histamine Phosphate—Dyspepsia—Doxorubicin—bone cancer	0.000221	0.00139	CcSEcCtD
Histamine Phosphate—Decreased appetite—Doxorubicin—bone cancer	0.000218	0.00137	CcSEcCtD
Histamine Phosphate—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000217	0.00136	CcSEcCtD
Histamine Phosphate—Fatigue—Doxorubicin—bone cancer	0.000216	0.00136	CcSEcCtD
Histamine Phosphate—Urticaria—Epirubicin—bone cancer	0.000215	0.00136	CcSEcCtD
Histamine Phosphate—Constipation—Doxorubicin—bone cancer	0.000215	0.00135	CcSEcCtD
Histamine Phosphate—Pain—Doxorubicin—bone cancer	0.000215	0.00135	CcSEcCtD
Histamine Phosphate—Body temperature increased—Epirubicin—bone cancer	0.000214	0.00135	CcSEcCtD
Histamine Phosphate—Abdominal pain—Epirubicin—bone cancer	0.000214	0.00135	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Methotrexate—bone cancer	0.000214	0.00134	CcSEcCtD
Histamine Phosphate—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000208	0.0134	CbGpPWpGaD
Histamine Phosphate—Asthenia—Methotrexate—bone cancer	0.000208	0.00131	CcSEcCtD
Histamine Phosphate—Feeling abnormal—Doxorubicin—bone cancer	0.000207	0.0013	CcSEcCtD
Histamine Phosphate—Gastrointestinal pain—Doxorubicin—bone cancer	0.000205	0.00129	CcSEcCtD
Histamine Phosphate—Pruritus—Methotrexate—bone cancer	0.000205	0.00129	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Epirubicin—bone cancer	0.0002	0.00126	CcSEcCtD
Histamine Phosphate—Urticaria—Doxorubicin—bone cancer	0.000199	0.00126	CcSEcCtD
Histamine Phosphate—Body temperature increased—Doxorubicin—bone cancer	0.000198	0.00125	CcSEcCtD
Histamine Phosphate—Abdominal pain—Doxorubicin—bone cancer	0.000198	0.00125	CcSEcCtD
Histamine Phosphate—Diarrhoea—Methotrexate—bone cancer	0.000198	0.00125	CcSEcCtD
Histamine Phosphate—Asthenia—Epirubicin—bone cancer	0.000195	0.00123	CcSEcCtD
Histamine Phosphate—Pruritus—Epirubicin—bone cancer	0.000192	0.00121	CcSEcCtD
Histamine Phosphate—Dizziness—Methotrexate—bone cancer	0.000192	0.00121	CcSEcCtD
Histamine Phosphate—CYP2D6—Xenobiotics—CYP3A4—bone cancer	0.000188	0.0121	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Xenobiotics—CYP3A4—bone cancer	0.000186	0.012	CbGpPWpGaD
Histamine Phosphate—Diarrhoea—Epirubicin—bone cancer	0.000186	0.00117	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Doxorubicin—bone cancer	0.000185	0.00116	CcSEcCtD
Histamine Phosphate—Vomiting—Methotrexate—bone cancer	0.000184	0.00116	CcSEcCtD
Histamine Phosphate—Rash—Methotrexate—bone cancer	0.000183	0.00115	CcSEcCtD
Histamine Phosphate—Dermatitis—Methotrexate—bone cancer	0.000183	0.00115	CcSEcCtD
Histamine Phosphate—Headache—Methotrexate—bone cancer	0.000182	0.00114	CcSEcCtD
Histamine Phosphate—CYP2D6—Tamoxifen metabolism—CYP3A4—bone cancer	0.000181	0.0116	CbGpPWpGaD
Histamine Phosphate—Asthenia—Doxorubicin—bone cancer	0.00018	0.00113	CcSEcCtD
Histamine Phosphate—Dizziness—Epirubicin—bone cancer	0.000179	0.00113	CcSEcCtD
Histamine Phosphate—CYP2C9—Tamoxifen metabolism—CYP3A4—bone cancer	0.000179	0.0115	CbGpPWpGaD
Histamine Phosphate—Pruritus—Doxorubicin—bone cancer	0.000178	0.00112	CcSEcCtD
Histamine Phosphate—Vomiting—Epirubicin—bone cancer	0.000172	0.00109	CcSEcCtD
Histamine Phosphate—Nausea—Methotrexate—bone cancer	0.000172	0.00108	CcSEcCtD
Histamine Phosphate—Diarrhoea—Doxorubicin—bone cancer	0.000172	0.00108	CcSEcCtD
Histamine Phosphate—Rash—Epirubicin—bone cancer	0.000171	0.00108	CcSEcCtD
Histamine Phosphate—Dermatitis—Epirubicin—bone cancer	0.000171	0.00108	CcSEcCtD
Histamine Phosphate—Headache—Epirubicin—bone cancer	0.00017	0.00107	CcSEcCtD
Histamine Phosphate—CYP2D6—Metapathway biotransformation—CYP4V2—bone cancer	0.000167	0.0108	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metapathway biotransformation—CYP4V2—bone cancer	0.000166	0.0107	CbGpPWpGaD
Histamine Phosphate—Dizziness—Doxorubicin—bone cancer	0.000166	0.00104	CcSEcCtD
Histamine Phosphate—Nausea—Epirubicin—bone cancer	0.000161	0.00101	CcSEcCtD
Histamine Phosphate—Vomiting—Doxorubicin—bone cancer	0.00016	0.001	CcSEcCtD
Histamine Phosphate—HRH3—GPCR ligand binding—GRM4—bone cancer	0.000159	0.0102	CbGpPWpGaD
Histamine Phosphate—Rash—Doxorubicin—bone cancer	0.000158	0.000996	CcSEcCtD
Histamine Phosphate—Dermatitis—Doxorubicin—bone cancer	0.000158	0.000995	CcSEcCtD
Histamine Phosphate—Headache—Doxorubicin—bone cancer	0.000157	0.00099	CcSEcCtD
Histamine Phosphate—Nausea—Doxorubicin—bone cancer	0.000149	0.000938	CcSEcCtD
Histamine Phosphate—HRH4—GPCR ligand binding—GRM4—bone cancer	0.000139	0.00891	CbGpPWpGaD
Histamine Phosphate—HRH3—GPCR ligand binding—GRM1—bone cancer	0.000138	0.00887	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000137	0.00883	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000128	0.00821	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000122	0.00782	CbGpPWpGaD
Histamine Phosphate—HRH4—GPCR ligand binding—GRM1—bone cancer	0.00012	0.00772	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000109	0.00703	CbGpPWpGaD
Histamine Phosphate—HRH2—GPCR ligand binding—GRM4—bone cancer	0.000108	0.00691	CbGpPWpGaD
Histamine Phosphate—HRH3—GPCR ligand binding—SMO—bone cancer	9.73e-05	0.00625	CbGpPWpGaD
Histamine Phosphate—CA4—Metabolism—NDUFA12—bone cancer	9.67e-05	0.00621	CbGpPWpGaD
Histamine Phosphate—HRH2—GPCR ligand binding—GRM1—bone cancer	9.32e-05	0.00599	CbGpPWpGaD
Histamine Phosphate—HRH1—G alpha (q) signalling events—GRM1—bone cancer	9.05e-05	0.00581	CbGpPWpGaD
Histamine Phosphate—HRH3—GPCR downstream signaling—GRM4—bone cancer	9e-05	0.00578	CbGpPWpGaD
Histamine Phosphate—HRH3—GPCR downstream signaling—RGS1—bone cancer	9e-05	0.00578	CbGpPWpGaD
Histamine Phosphate—HRH4—GPCR ligand binding—SMO—bone cancer	8.47e-05	0.00544	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling by GPCR—GRM4—bone cancer	8.18e-05	0.00525	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling by GPCR—RGS1—bone cancer	8.18e-05	0.00525	CbGpPWpGaD
Histamine Phosphate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GRM1—bone cancer	8.09e-05	0.0052	CbGpPWpGaD
Histamine Phosphate—CA4—Metabolism—NT5C3A—bone cancer	8.02e-05	0.00515	CbGpPWpGaD
Histamine Phosphate—SLC22A3—Transmembrane transport of small molecules—TUBB4B—bone cancer	7.97e-05	0.00512	CbGpPWpGaD
Histamine Phosphate—SLC22A5—Transmembrane transport of small molecules—TUBB4B—bone cancer	7.95e-05	0.00511	CbGpPWpGaD
Histamine Phosphate—HRH4—GPCR downstream signaling—GRM4—bone cancer	7.84e-05	0.00503	CbGpPWpGaD
Histamine Phosphate—HRH4—GPCR downstream signaling—RGS1—bone cancer	7.84e-05	0.00503	CbGpPWpGaD
Histamine Phosphate—HRH3—GPCR downstream signaling—GRM1—bone cancer	7.81e-05	0.00501	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	7.8e-05	0.00501	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	7.73e-05	0.00497	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	7.7e-05	0.00494	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	7.63e-05	0.0049	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling by GPCR—RGS1—bone cancer	7.12e-05	0.00457	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling by GPCR—GRM4—bone cancer	7.12e-05	0.00457	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling by GPCR—GRM1—bone cancer	7.09e-05	0.00455	CbGpPWpGaD
Histamine Phosphate—SLC22A3—Transmembrane transport of small molecules—TUBB2A—bone cancer	6.88e-05	0.00442	CbGpPWpGaD
Histamine Phosphate—SLC22A5—Transmembrane transport of small molecules—TUBB2A—bone cancer	6.86e-05	0.00441	CbGpPWpGaD
Histamine Phosphate—HRH4—GPCR downstream signaling—GRM1—bone cancer	6.8e-05	0.00437	CbGpPWpGaD
Histamine Phosphate—HRH2—GPCR ligand binding—SMO—bone cancer	6.57e-05	0.00422	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	6.32e-05	0.00406	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	6.27e-05	0.00403	CbGpPWpGaD
Histamine Phosphate—SLC22A3—Metabolism—NDUFA12—bone cancer	6.23e-05	0.004	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling by GPCR—GRM1—bone cancer	6.17e-05	0.00396	CbGpPWpGaD
Histamine Phosphate—HRH2—GPCR downstream signaling—RGS1—bone cancer	6.08e-05	0.0039	CbGpPWpGaD
Histamine Phosphate—HRH2—GPCR downstream signaling—GRM4—bone cancer	6.08e-05	0.0039	CbGpPWpGaD
Histamine Phosphate—HRH1—G alpha (q) signalling events—GNA11—bone cancer	5.83e-05	0.00375	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling by GPCR—RGS1—bone cancer	5.52e-05	0.00355	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling by GPCR—GRM4—bone cancer	5.52e-05	0.00355	CbGpPWpGaD
Histamine Phosphate—HRH2—GPCR downstream signaling—GRM1—bone cancer	5.27e-05	0.00338	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCR ligand binding—GRM4—bone cancer	5.26e-05	0.00338	CbGpPWpGaD
Histamine Phosphate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—bone cancer	5.21e-05	0.00335	CbGpPWpGaD
Histamine Phosphate—SLC22A3—Metabolism—NT5C3A—bone cancer	5.17e-05	0.00332	CbGpPWpGaD
Histamine Phosphate—HRH3—GPCR downstream signaling—GNA11—bone cancer	5.03e-05	0.00323	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Transmembrane transport of small molecules—TUBB4B—bone cancer	5e-05	0.00321	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling by GPCR—SMO—bone cancer	4.99e-05	0.00321	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—GRM4—bone cancer	4.83e-05	0.0031	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—RGS1—bone cancer	4.83e-05	0.0031	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling by GPCR—GRM1—bone cancer	4.79e-05	0.00307	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Transmembrane transport of small molecules—TUBB4B—bone cancer	4.66e-05	0.00299	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling by GPCR—GNA11—bone cancer	4.57e-05	0.00293	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCR ligand binding—GRM1—bone cancer	4.56e-05	0.00293	CbGpPWpGaD
Histamine Phosphate—HRH3—GPCR downstream signaling—IL3—bone cancer	4.56e-05	0.00293	CbGpPWpGaD
Histamine Phosphate—HRH4—GPCR downstream signaling—GNA11—bone cancer	4.38e-05	0.00281	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling by GPCR—SMO—bone cancer	4.35e-05	0.00279	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	4.32e-05	0.00277	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—RGS1—bone cancer	4.2e-05	0.0027	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—GRM4—bone cancer	4.2e-05	0.0027	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—GRM1—bone cancer	4.19e-05	0.00269	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling by GPCR—IL3—bone cancer	4.14e-05	0.00266	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Transmembrane transport of small molecules—TUBB2A—bone cancer	4.02e-05	0.00258	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling by GPCR—GNA11—bone cancer	3.98e-05	0.00255	CbGpPWpGaD
Histamine Phosphate—HRH4—GPCR downstream signaling—IL3—bone cancer	3.97e-05	0.00255	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	3.96e-05	0.00255	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—NDUFA12—bone cancer	3.91e-05	0.00251	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—GRM1—bone cancer	3.65e-05	0.00234	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—NDUFA12—bone cancer	3.64e-05	0.00234	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling by GPCR—IL3—bone cancer	3.61e-05	0.00232	CbGpPWpGaD
Histamine Phosphate—CA4—Metabolism—ENO2—bone cancer	3.51e-05	0.00226	CbGpPWpGaD
Histamine Phosphate—HRH2—GPCR downstream signaling—GNA11—bone cancer	3.4e-05	0.00218	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling by GPCR—SMO—bone cancer	3.37e-05	0.00217	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Biological oxidations—CYP3A4—bone cancer	3.36e-05	0.00216	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Biological oxidations—CYP3A4—bone cancer	3.33e-05	0.00214	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	3.31e-05	0.00213	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	3.28e-05	0.00211	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—GRM4—bone cancer	3.26e-05	0.00209	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—RGS1—bone cancer	3.26e-05	0.00209	CbGpPWpGaD
Histamine Phosphate—CA4—Metabolism—DHFR—bone cancer	3.26e-05	0.00209	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—NT5C3A—bone cancer	3.24e-05	0.00208	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCR ligand binding—SMO—bone cancer	3.22e-05	0.00207	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Transmission across Chemical Synapses—BRAF—bone cancer	3.17e-05	0.00204	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling by GPCR—GNA11—bone cancer	3.08e-05	0.00198	CbGpPWpGaD
Histamine Phosphate—HRH2—GPCR downstream signaling—IL3—bone cancer	3.08e-05	0.00198	CbGpPWpGaD
Histamine Phosphate—CA4—Metabolism—GNA11—bone cancer	3.04e-05	0.00196	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—NT5C3A—bone cancer	3.02e-05	0.00194	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCR downstream signaling—RGS1—bone cancer	2.97e-05	0.00191	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCR downstream signaling—GRM4—bone cancer	2.97e-05	0.00191	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Transmission across Chemical Synapses—BRAF—bone cancer	2.96e-05	0.0019	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—SMO—bone cancer	2.95e-05	0.0019	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	2.9e-05	0.00186	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Biological oxidations—GSTP1—bone cancer	2.87e-05	0.00184	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Biological oxidations—GSTP1—bone cancer	2.85e-05	0.00183	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	2.83e-05	0.00182	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—GRM1—bone cancer	2.83e-05	0.00182	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	2.81e-05	0.0018	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling by GPCR—IL3—bone cancer	2.8e-05	0.0018	CbGpPWpGaD
Histamine Phosphate—CA4—Metabolism—CYP3A4—bone cancer	2.76e-05	0.00177	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—RGS1—bone cancer	2.7e-05	0.00174	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—GRM4—bone cancer	2.7e-05	0.00174	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—GNA11—bone cancer	2.7e-05	0.00173	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Transmission across Chemical Synapses—MDM2—bone cancer	2.66e-05	0.00171	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCR downstream signaling—GRM1—bone cancer	2.58e-05	0.00166	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—SMO—bone cancer	2.57e-05	0.00165	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—ATF1—bone cancer	2.51e-05	0.00161	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Transmission across Chemical Synapses—MDM2—bone cancer	2.48e-05	0.00159	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—IL3—bone cancer	2.45e-05	0.00157	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Neuronal System—BRAF—bone cancer	2.43e-05	0.00156	CbGpPWpGaD
Histamine Phosphate—CA4—Metabolism—GSTP1—bone cancer	2.36e-05	0.00152	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—GNA11—bone cancer	2.35e-05	0.00151	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—GRM1—bone cancer	2.34e-05	0.0015	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Neuronal System—BRAF—bone cancer	2.26e-05	0.00145	CbGpPWpGaD
Histamine Phosphate—SLC22A3—Metabolism—ENO2—bone cancer	2.26e-05	0.00145	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—ATF1—bone cancer	2.18e-05	0.0014	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—IL3—bone cancer	2.13e-05	0.00137	CbGpPWpGaD
Histamine Phosphate—SLC22A3—Metabolism—DHFR—bone cancer	2.1e-05	0.00135	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—TGFBR2—bone cancer	2.09e-05	0.00134	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Neuronal System—MDM2—bone cancer	2.04e-05	0.00131	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—NDUFA12—bone cancer	2.01e-05	0.00129	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—NDUFA12—bone cancer	2e-05	0.00128	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—SMO—bone cancer	1.99e-05	0.00128	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—IGF1R—bone cancer	1.97e-05	0.00126	CbGpPWpGaD
Histamine Phosphate—SLC22A3—Metabolism—GNA11—bone cancer	1.96e-05	0.00126	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Neuronal System—MDM2—bone cancer	1.9e-05	0.00122	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Biological oxidations—GSTP1—bone cancer	1.88e-05	0.00121	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	1.85e-05	0.00119	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—TGFBR2—bone cancer	1.82e-05	0.00117	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—GNA11—bone cancer	1.82e-05	0.00117	CbGpPWpGaD
Histamine Phosphate—SLC22A3—Metabolism—CYP3A4—bone cancer	1.78e-05	0.00114	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—IGF1R—bone cancer	1.71e-05	0.0011	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—ATF1—bone cancer	1.69e-05	0.00109	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—NT5C3A—bone cancer	1.67e-05	0.00107	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCR downstream signaling—GNA11—bone cancer	1.66e-05	0.00107	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—NT5C3A—bone cancer	1.65e-05	0.00106	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—IL3—bone cancer	1.65e-05	0.00106	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—SMO—bone cancer	1.65e-05	0.00106	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—GRM4—bone cancer	1.6e-05	0.00102	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—RGS1—bone cancer	1.6e-05	0.00102	CbGpPWpGaD
Histamine Phosphate—SLC22A3—Metabolism—GSTP1—bone cancer	1.52e-05	0.000977	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—GNA11—bone cancer	1.51e-05	0.000969	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCR downstream signaling—IL3—bone cancer	1.51e-05	0.000968	CbGpPWpGaD
Histamine Phosphate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	1.48e-05	0.000954	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—KIT—bone cancer	1.43e-05	0.000917	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—ENO2—bone cancer	1.42e-05	0.000912	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—TGFBR2—bone cancer	1.41e-05	0.000907	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—GRM1—bone cancer	1.38e-05	0.000889	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—IL3—bone cancer	1.37e-05	0.000879	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—BRAF—bone cancer	1.34e-05	0.000862	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—IGF1R—bone cancer	1.33e-05	0.000854	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—ENO2—bone cancer	1.32e-05	0.00085	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—DHFR—bone cancer	1.32e-05	0.000846	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—NDUFA12—bone cancer	1.32e-05	0.000845	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling by GPCR—EGFR—bone cancer	1.3e-05	0.000836	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—KIT—bone cancer	1.24e-05	0.000798	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—GNA11—bone cancer	1.23e-05	0.00079	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—DHFR—bone cancer	1.23e-05	0.000788	CbGpPWpGaD
Histamine Phosphate—CA4—Metabolism—PTGS2—bone cancer	1.22e-05	0.000786	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—BRAF—bone cancer	1.17e-05	0.00075	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—GNA11—bone cancer	1.15e-05	0.000737	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling by GPCR—EGFR—bone cancer	1.13e-05	0.000727	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—MDM2—bone cancer	1.12e-05	0.000722	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—CYP3A4—bone cancer	1.12e-05	0.000717	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—NT5C3A—bone cancer	1.09e-05	0.0007	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—CYP3A4—bone cancer	1.04e-05	0.000668	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—MDM2—bone cancer	9.79e-06	0.000629	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—JUN—bone cancer	9.77e-06	0.000628	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—SMO—bone cancer	9.75e-06	0.000626	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—KIT—bone cancer	9.64e-06	0.000619	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—GSTP1—bone cancer	9.54e-06	0.000613	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—MMP9—bone cancer	9.51e-06	0.000611	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—BRAF—bone cancer	9.06e-06	0.000582	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—GNA11—bone cancer	8.91e-06	0.000573	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—GSTP1—bone cancer	8.89e-06	0.000571	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling by GPCR—EGFR—bone cancer	8.78e-06	0.000564	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—JUN—bone cancer	8.51e-06	0.000547	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—ATF1—bone cancer	8.29e-06	0.000532	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—MMP9—bone cancer	8.28e-06	0.000532	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—IL3—bone cancer	8.08e-06	0.000519	CbGpPWpGaD
Histamine Phosphate—SLC22A3—Metabolism—PTGS2—bone cancer	7.88e-06	0.000506	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—EGFR—bone cancer	7.68e-06	0.000494	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—MDM2—bone cancer	7.59e-06	0.000488	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—ENO2—bone cancer	7.31e-06	0.000469	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—ENO2—bone cancer	7.24e-06	0.000465	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—TGFBR2—bone cancer	6.91e-06	0.000444	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—DHFR—bone cancer	6.78e-06	0.000435	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—DHFR—bone cancer	6.72e-06	0.000432	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—EGFR—bone cancer	6.69e-06	0.00043	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—JUN—bone cancer	6.6e-06	0.000424	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—IGF1R—bone cancer	6.5e-06	0.000418	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—TP53—bone cancer	6.45e-06	0.000414	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—MMP9—bone cancer	6.42e-06	0.000412	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—GNA11—bone cancer	6.33e-06	0.000407	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—GNA11—bone cancer	6.28e-06	0.000403	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—CYP3A4—bone cancer	5.74e-06	0.000369	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—CYP3A4—bone cancer	5.69e-06	0.000366	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	5.66e-06	0.000364	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—TP53—bone cancer	5.62e-06	0.000361	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—EGFR—bone cancer	5.19e-06	0.000333	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—PTGS2—bone cancer	4.94e-06	0.000317	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—GSTP1—bone cancer	4.91e-06	0.000315	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—GSTP1—bone cancer	4.87e-06	0.000313	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—ENO2—bone cancer	4.78e-06	0.000307	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—KIT—bone cancer	4.72e-06	0.000303	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—PTGS2—bone cancer	4.61e-06	0.000296	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—BRAF—bone cancer	4.43e-06	0.000285	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—DHFR—bone cancer	4.43e-06	0.000285	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—TP53—bone cancer	4.35e-06	0.00028	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—EGFR—bone cancer	4.3e-06	0.000276	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—GNA11—bone cancer	4.14e-06	0.000266	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—MDM2—bone cancer	3.71e-06	0.000239	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—JUN—bone cancer	3.23e-06	0.000207	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—GSTP1—bone cancer	3.21e-06	0.000206	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—MMP9—bone cancer	3.14e-06	0.000202	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—PTGS2—bone cancer	2.54e-06	0.000163	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—EGFR—bone cancer	2.54e-06	0.000163	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—PTGS2—bone cancer	2.52e-06	0.000162	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—TP53—bone cancer	2.13e-06	0.000137	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—PTGS2—bone cancer	1.66e-06	0.000107	CbGpPWpGaD
